<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19779565</PMID><DateCompleted><Year>2010</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>9</Issue><PubDate><Year>2009</Year><Month>Sep</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation.</ArticleTitle><Pagination><StartPage>e1000593</StartPage><MedlinePgn>e1000593</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1000593</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1000593</ELocationID><Abstract><AbstractText>Identification of novel cellular proteins as substrates to viral proteases would provide a new insight into the mechanism of cell-virus interplay. Eight nuclear proteins as potential targets for enterovirus 71 (EV71) 3C protease (3C(pro)) cleavages were identified by 2D electrophoresis and MALDI-TOF analysis. Of these proteins, CstF-64, which is a critical factor for 3' pre-mRNA processing in a cell nucleus, was selected for further study. A time-course study to monitor the expression levels of CstF-64 in EV71-infected cells also revealed that the reduction of CstF-64 during virus infection was correlated with the production of viral 3C(pro). CstF-64 was cleaved in vitro by 3C(pro) but neither by mutant 3C(pro) (in which the catalytic site was inactivated) nor by another EV71 protease 2A(pro). Serial mutagenesis was performed in CstF-64, revealing that the 3C(pro) cleavage sites are located at position 251 in the N-terminal P/G-rich domain and at multiple positions close to the C-terminus of CstF-64 (around position 500). An accumulation of unprocessed pre-mRNA and the depression of mature mRNA were observed in EV71-infected cells. An in vitro assay revealed the inhibition of the 3'-end pre-mRNA processing and polyadenylation in 3C(pro)-treated nuclear extract, and this impairment was rescued by adding purified recombinant CstF-64 protein. In summing up the above results, we suggest that 3C(pro) cleavage inactivates CstF-64 and impairs the host cell polyadenylation in vitro, as well as in virus-infected cells. This finding is, to our knowledge, the first to demonstrate that a picornavirus protein affects the polyadenylation of host mRNA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Kuo-Feng</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, Chang Gung University, Kwei-Shan Tao-Yuan, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mei-Ling</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Chuan-Tien</ForeName><Initials>CT</Initials></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Shin-Ru</ForeName><Initials>SR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C474466">CSTF2T protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039241">Cleavage Stimulation Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012322">RNA Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>24937-83-5</RegistryNumber><NameOfSubstance UI="D011061">Poly A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039241" MajorTopicYN="N">Cleavage Stimulation Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015180" MajorTopicYN="N">Electrophoresis, Gel, Two-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011061" MajorTopicYN="N">Poly A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026723" MajorTopicYN="N">Polyadenylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025941" MajorTopicYN="N">Protein Interaction Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012322" MajorTopicYN="N">RNA Precursors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019032" MajorTopicYN="N">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2009</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19779565</ArticleId><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1000593</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999;341:929&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SB, Liao H, Huang CH, Tan QY, Zhang WL, et al. [Serum types of enterovirus and clinical characteristics of 237 children with hand, foot and mouth disease in Shenzhen]. Zhongguo Dang Dai Er Ke Za Zhi. 2008;10:38&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">18289469</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S, Chee HY, Al-Kobaisi MF, Xiaoshan J, Chua KB, et al. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 1999;61:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, et al. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol. 2001;75:7732&#x2013;7738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC115010</ArticleId><ArticleId IdType="pubmed">11462047</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 2001;32:236&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26:91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert GL, Dickson KE, Waters MJ, Kennett ML, Land SA, et al. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J. 1988;7:484&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">2841639</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JP, , Jr., Baden L, Pallansch MA, Anderson LJ. Enterovirus 71 infections and neurologic disease&#x2013;United States, 1977&#x2013;1991. J Infect Dis. 1994;169:905&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehle J, Roth B, Metzger C, Pfitzner A, Enders G. Molecular characterization of an Enterovirus 71 causing neurological disease in Germany. J Neurovirol. 2003;9:126&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">12587076</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S, Sam IC, Yusof J, Lim MK, Misbah S, et al. Enterovirus 71 outbreak, Brunei. Emerg Infect Dis. 2009;15:79&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2660687</ArticleId><ArticleId IdType="pubmed">19116058</ArticleId></ArticleIdList></Reference><Reference><Citation>Etchison D, Milburn SC, Edery I, Sonenberg N, Hershey JW. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem. 1982;257:14806&#x2013;14810.</Citation><ArticleIdList><ArticleId IdType="pubmed">6294080</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose JK, Trachsel H, Leong K, Baltimore D. Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc Natl Acad Sci U S A. 1978;75:2732&#x2013;2736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC392637</ArticleId><ArticleId IdType="pubmed">208073</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark ME, Hammerle T, Wimmer E, Dasgupta A. Poliovirus proteinase 3C converts an active form of transcription factor IIIC to an inactive form: a mechanism for inhibition of host cell polymerase III transcription by poliovirus. Embo J. 1991;10:2941&#x2013;2947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC453008</ArticleId><ArticleId IdType="pubmed">1915271</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark ME, Lieberman PM, Berk AJ, Dasgupta A. Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol Cell Biol. 1993;13:1232&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC359008</ArticleId><ArticleId IdType="pubmed">8380894</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammerle T, Hellen CU, Wimmer E. Site-directed mutagenesis of the putative catalytic triad of poliovirus 3C proteinase. J Biol Chem. 1991;266:5412&#x2013;5416.</Citation><ArticleIdList><ArticleId IdType="pubmed">1848550</ArticleId></ArticleIdList></Reference><Reference><Citation>Kean KM, Teterina NL, Marc D, Girard M. Analysis of putative active site residues of the poliovirus 3C protease. Virology. 1991;181:609&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pubmed">1849679</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews DA, Smith WW, Ferre RA, Condon B, Budahazi G, et al. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell. 1994;77:761&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pubmed">7515772</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosimann SC, Cherney MM, Sia S, Plotch S, James MN. Refined X-ray crystallographic structure of the poliovirus 3C gene product. J Mol Biol. 1997;273:1032&#x2013;1047.</Citation><ArticleIdList><ArticleId IdType="pubmed">9367789</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Chiang C, Chen TC, Wu CN, Hsu JT, et al. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J Biomed Sci. 2004;11:239&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">14966374</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, Hsu TA, Chen TC, Chang SC, Lee JC, et al. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 2002;293:386&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura N, Semler BL, Rothberg PG, Larsen GR, Adler CJ, et al. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature. 1981;291:547&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pubmed">6264310</ArticleId></ArticleIdList></Reference><Reference><Citation>Amineva SP, Aminev AG, Palmenberg AC, Gern JE. Rhinovirus 3C protease precursors 3CD and 3CD&#x2032; localize to the nuclei of infected cells. J Gen Virol. 2004;85:2969&#x2013;2979.</Citation><ArticleIdList><ArticleId IdType="pubmed">15448360</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Raychaudhuri S, Dasgupta A. Nuclear entry of poliovirus protease-polymerase precursor 3CD: implications for host cell transcription shut-off. Virology. 2004;320:195&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">15016543</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalamanchili P, Datta U, Dasgupta A. Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro. J Virol. 1997;71:1220&#x2013;1226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191176</ArticleId><ArticleId IdType="pubmed">8995645</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalamanchili P, Weidman K, Dasgupta A. Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro. Virology. 1997;239:176&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">9426457</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk MM, Grigera PR, Bergmann IE, Zibert A, Multhaup G, et al. Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J Virol. 1990;64:748&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC249169</ArticleId><ArticleId IdType="pubmed">2153239</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidman MK, Yalamanchili P, Ng B, Tsai W, Dasgupta A. Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity. Virology. 2001;291:260&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">11878895</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford LP, Bagga PS, Wilusz J. The poly(A) tail inhibits the assembly of a 3&#x2032;-to-5&#x2032; exonuclease in an in vitro RNA stability system. Mol Cell Biol. 1997;17:398&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC231764</ArticleId><ArticleId IdType="pubmed">8972220</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Carmichael GG. Role of polyadenylation in nucleocytoplasmic transport of mRNA. Mol Cell Biol. 1996;16:1534&#x2013;1542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC231138</ArticleId><ArticleId IdType="pubmed">8657127</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachs AB, Sarnow P, Hentze MW. Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell. 1997;89:831&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pubmed">9200601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickens M, Anderson P, Jackson RJ. Life and death in the cytoplasm: messages from the 3&#x2032; end. Curr Opin Genet Dev. 1997;7:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">9115434</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestri LS, Parilla JM, Morasco BJ, Ogram SA, Flanegan JB. Relationship between poliovirus negative-strand RNA synthesis and the length of the 3&#x2032; poly(A) tail. Virology. 2006;345:509&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">16297425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusov YY, Gosert R, Gauss-Muller V. Replication and in vivo repair of the hepatitis A virus genome lacking the poly(A) tail. J Gen Virol. 2005;86:1363&#x2013;1368.</Citation><ArticleIdList><ArticleId IdType="pubmed">15831948</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsch-Hasler K, Yogo Y, Wimmer E. Replication of picornaviruses. I. Evidence from in vitro RNA synthesis that poly(A) of the poliovirus genome is genetically coded. J Virol. 1975;16:1512&#x2013;1517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC355760</ArticleId><ArticleId IdType="pubmed">172656</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Hyman L, Moore C. Formation of mRNA 3&#x2032; ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev. 1999;63:405&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC98971</ArticleId><ArticleId IdType="pubmed">10357856</ArticleId></ArticleIdList></Reference><Reference><Citation>Colgan DF, Manley JL. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 1997;11:2755&#x2013;2766.</Citation><ArticleIdList><ArticleId IdType="pubmed">9353246</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald CC, Wilusz J, Shenk T. The 64-kilodalton subunit of the CstF polyadenylation factor binds to pre-mRNAs downstream of the cleavage site and influences cleavage site location. Mol Cell Biol. 1994;14:6647&#x2013;6654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC359194</ArticleId><ArticleId IdType="pubmed">7935383</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagaki Y, Manley JL, MacDonald CC, Wilusz J, Shenk T. A multisubunit factor, CstF, is required for polyadenylation of mammalian pre-mRNAs. Genes Dev. 1990;4:2112&#x2013;2120.</Citation><ArticleIdList><ArticleId IdType="pubmed">1980119</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Zhou HL, Hasman RA, Lou H. Hu proteins regulate polyadenylation by blocking sites containing U-rich sequences. J Biol Chem. 2007;282:2203&#x2013;2210.</Citation><ArticleIdList><ArticleId IdType="pubmed">17127772</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace AM, Denison TL, Attaya EN, MacDonald CC. Developmental distribution of the polyadenylation protein CstF-64 and the variant tauCstF-64 in mouse and rat testis. Biol Reprod. 2004;70:1080&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pubmed">14681198</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustin KE, Sarnow P. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. Embo J. 2001;20:240&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140206</ArticleId><ArticleId IdType="pubmed">11226174</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustin KE, Sarnow P. Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J Virol. 2002;76:8787&#x2013;8796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136411</ArticleId><ArticleId IdType="pubmed">12163599</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Li ML, Huang PN, Chien KY, Horng JT, et al. Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5&#x2032; untranslated region and participates in virus replication. J Gen Virol. 2008;89:2540&#x2013;2549.</Citation><ArticleIdList><ArticleId IdType="pubmed">18796723</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Tomas C. The presence of viral-induced proteins in nuclei from poliovirus-infected HeLa cells. Virology. 1982;116:629&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pubmed">6278731</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Stollar V, Lin JY, Chang SC, Chen GW, et al. Identification of genes involved in the host response to enterovirus 71 infection. J Neurovirol. 2004;10:293&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">15385252</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Li ML, Shih SR. Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res. 2009;37:47&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615614</ArticleId><ArticleId IdType="pubmed">19010963</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagaki Y, MacDonald CC, Shenk T, Manley JL. The human 64-kDa polyadenylylation factor contains a ribonucleoprotein-type RNA binding domain and unusual auxiliary motifs. Proc Natl Acad Sci U S A. 1992;89:1403&#x2013;1407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC48459</ArticleId><ArticleId IdType="pubmed">1741396</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Canadillas JM, Varani G. Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein. Embo J. 2003;22:2821&#x2013;2830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC156756</ArticleId><ArticleId IdType="pubmed">12773396</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagaki Y, Manley JL. Complex protein interactions within the human polyadenylation machinery identify a novel component. Mol Cell Biol. 2000;20:1515&#x2013;1525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC85326</ArticleId><ArticleId IdType="pubmed">10669729</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatton LS, Eloranta JJ, Figueiredo LM, Takagaki Y, Manley JL, et al. The Drosophila homologue of the 64 kDa subunit of cleavage stimulation factor interacts with the 77 kDa subunit encoded by the suppressor of forked gene. Nucleic Acids Res. 2000;28:520&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102530</ArticleId><ArticleId IdType="pubmed">10606651</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo O, Manley JL. Evolutionarily conserved interaction between CstF-64 and PC4 links transcription, polyadenylation, and termination. Mol Cell. 2001;7:1013&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pubmed">11389848</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu X, Perez-Canadillas JM, Agrawal S, De Baecke J, Cheng H, et al. The C-terminal domains of vertebrate CstF-64 and its yeast orthologue Rna15 form a new structure critical for mRNA 3&#x2032;-end processing. J Biol Chem. 2007;282:2101&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pubmed">17116658</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3&#x2032;end formation of cellular pre-mRNAs. Mol Cell. 1998;1:991&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pubmed">9651582</ArticleId></ArticleIdList></Reference><Reference><Citation>Noah DL, Twu KY, Krug RM. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3&#x2032; end processing of cellular pre-mRNAS. Virology. 2003;307:386&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">12667806</ArticleId></ArticleIdList></Reference><Reference><Citation>Twu KY, Kuo RL, Marklund J, Krug RM. The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol. 2007;81:8112&#x2013;8121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1951328</ArticleId><ArticleId IdType="pubmed">17522219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnow P. Translation of glucose-regulated protein 78/immunoglobulin heavy-chain binding protein mRNA is increased in poliovirus-infected cells at a time when cap-dependent translation of cellular mRNAs is inhibited. Proc Natl Acad Sci U S A. 1989;86:5795&#x2013;5799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC297717</ArticleId><ArticleId IdType="pubmed">2548189</ArticleId></ArticleIdList></Reference><Reference><Citation>Macejak DG, Sarnow P. Internal initiation of translation mediated by the 5&#x2032; leader of a cellular mRNA. Nature. 1991;353:90&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">1652694</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannes G, Sarnow P. Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites. Rna. 1998;4:1500&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369721</ArticleId><ArticleId IdType="pubmed">9848649</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>